Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.

por Stephens, T. C., Courtenay, V. D., Mills, J., Peacock, J. H., Rose, C. M., Spooner, D.
Publicado 1981

A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer

por Hussain, S A, Stocken, D D, Riley, P, Palmer, D H, Peake, D R, Geh, J I, Spooner, D, James, N D
Publicado 2004

Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma

por Haniball, J., Sumathi, V. P., Kindblom, L.-G., Abudu, A., Carter, S. R., Tillman, R. M., Jeys, L., Spooner, D., Peake, D., Grimer, R. J.
Publicado 2011

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer

por Hussain, S A, Ganesan, R, Reynolds, G, Gross, L, Stevens, A, Pastorek, J, Murray, P G, Perunovic, B, Anwar, M S, Billingham, L, James, N D, Spooner, D, Poole, C J, Rea, D W, Palmer, D H
Publicado 2007

NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life

por Earl, H M, Hiller, L, Dunn, J A, Bathers, S, Harvey, P, Stanley, A, Grieve, R J, Agrawal, R K, Fernando, I N, Brunt, A M, McAdam, K, O'Reilly, S, Rea, D W, Spooner, D, Poole, C J
Publicado 2008

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised...

por Earl, H M, Hiller, L, Dunn, J A, Vallier, A-L, Bowden, S J, Jordan, S D, Blows, F, Munro, A, Bathers, S, Grieve, R, Spooner, D A, Agrawal, R, Fernando, I, Brunt, A M, O'Reilly, S M, Crawford, S M, Rea, D W, Simmonds, P, Mansi, J L, Stanley, A, McAdam, K, Foster, L, Leonard, R CF, Twelves, C J, Cameron, D, Bartlett, J MS, Pharoah, P, Provenzano, E, Caldas, C, Poole, C J
Publicado 2012